SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by nearly 10%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate t